Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

GMP Audit Findings

CAPA SOP Fails to Link Deviation Investigations: A Critical GMP Disconnect

Posted on By

CAPA SOP Fails to Link Deviation Investigations: A Critical GMP Disconnect Why CAPA SOPs Must Be Aligned with Deviation Investigation Procedures Introduction to the Audit Finding 1. Finding Summary When Corrective and Preventive Action (CAPA) SOPs operate in isolation, without referencing the associated deviation handling SOPs, it creates a major GMP system disconnect. This weakens…

Read More “CAPA SOP Fails to Link Deviation Investigations: A Critical GMP Disconnect” »

CAPA Integration, GMP Audit Findings

CAPA SOPs Without Effectiveness Check Methodology: A Compliance Weakness

Posted on By

CAPA SOPs Without Effectiveness Check Methodology: A Compliance Weakness Why Effectiveness Checks Must Be Defined in Every CAPA SOP Introduction to the Audit Finding 1. Core Finding Many organizations implement Corrective and Preventive Actions (CAPA) but fail to define effectiveness check methodologies in their SOPs. This omission leaves the system vulnerable to recurring deviations and…

Read More “CAPA SOPs Without Effectiveness Check Methodology: A Compliance Weakness” »

CAPA Integration, GMP Audit Findings

Delayed CAPA Implementation Due to Ambiguous SOPs: A Regulatory Time Bomb

Posted on By

Delayed CAPA Implementation Due to Ambiguous SOPs: A Regulatory Time Bomb How Ambiguous SOPs Cause Dangerous Delays in CAPA Implementation Introduction to the Audit Finding 1. Nature of the Gap CAPA procedures that lack clarity often lead to delayed or inconsistent implementation. These delays directly impact the timely resolution of quality issues and increase regulatory…

Read More “Delayed CAPA Implementation Due to Ambiguous SOPs: A Regulatory Time Bomb” »

CAPA Integration, GMP Audit Findings

CAPA Records Without Reference to Originating Failures: A Hidden GMP Risk

Posted on By

CAPA Records Without Reference to Originating Failures: A Hidden GMP Risk Why Linking CAPA Records to Originating Failures Is Non-Negotiable Introduction to the Audit Finding 1. Summary of the Compliance Gap Many pharmaceutical companies maintain Corrective and Preventive Action (CAPA) records that fail to explicitly reference the original deviation, complaint, audit finding, or non-conformance that…

Read More “CAPA Records Without Reference to Originating Failures: A Hidden GMP Risk” »

CAPA Integration, GMP Audit Findings

Absence of SOP for Tracking Recurring CAPAs: A Critical GMP Oversight

Posted on By

Absence of SOP for Tracking Recurring CAPAs: A Critical GMP Oversight Why Not Tracking Recurring CAPAs Is a Major Compliance Weakness Introduction to the Audit Finding 1. Overview of the Issue Pharmaceutical facilities often implement Corrective and Preventive Actions (CAPAs) but fail to track recurring CAPAs due to the absence of a structured SOP. This…

Read More “Absence of SOP for Tracking Recurring CAPAs: A Critical GMP Oversight” »

CAPA Integration, GMP Audit Findings

Validation Protocols Not Aligned with SOP Instructions: Bridging the GMP Compliance Gap

Posted on By

Validation Protocols Not Aligned with SOP Instructions: Bridging the GMP Compliance Gap How Misaligned Validation Protocols and SOPs Compromise GMP Compliance Introduction to the Audit Finding 1. Definition of the Compliance Gap Validation protocols are often found to diverge from the standard operating procedures (SOPs) governing the same process or equipment. This creates a disconnect…

Read More “Validation Protocols Not Aligned with SOP Instructions: Bridging the GMP Compliance Gap” »

GMP Audit Findings, Validation Alignment

Missing Validation Requirements in SOPs for Critical Parameters: A GMP Red Flag

Posted on By

Missing Validation Requirements in SOPs for Critical Parameters: A GMP Red Flag How SOPs Missing Validation for Critical Parameters Jeopardize GMP Compliance Introduction to the Audit Finding 1. Nature of the Problem Standard Operating Procedures (SOPs) often fail to define validation requirements for critical process or equipment parameters. This omission leads to unvalidated steps being…

Read More “Missing Validation Requirements in SOPs for Critical Parameters: A GMP Red Flag” »

GMP Audit Findings, Validation Alignment

Inconsistencies Between Process Validation SOPs and Actual Practices: A Critical GMP Concern

Posted on By

Inconsistencies Between Process Validation SOPs and Actual Practices: A Critical GMP Concern When Process Validation SOPs Diverge from Practice: Closing the GMP Gap Introduction to the Audit Finding 1. Defining the Issue Process validation SOPs are often detailed, but their execution in actual operations may not fully align. This disconnect signals non-compliance and poor oversight….

Read More “Inconsistencies Between Process Validation SOPs and Actual Practices: A Critical GMP Concern” »

GMP Audit Findings, Validation Alignment

GMP Audit Risk: Poor Linkage Between Cleaning Validation Plan and SOPs

Posted on By

GMP Audit Risk: Poor Linkage Between Cleaning Validation Plan and SOPs Why Poor Linkage Between Cleaning Validation Plans and SOPs Threatens GMP Compliance Introduction to the Audit Finding 1. Defining the Issue Cleaning validation plans and SOPs are often developed in silos. This disconnection results in procedures being executed without appropriate validation reference, raising compliance…

Read More “GMP Audit Risk: Poor Linkage Between Cleaning Validation Plan and SOPs” »

GMP Audit Findings, Validation Alignment

Audit Risk: Outdated Qualification Procedures in SOPs Jeopardize GMP Compliance

Posted on By

Audit Risk: Outdated Qualification Procedures in SOPs Jeopardize GMP Compliance Why Referencing Outdated Qualification Procedures in SOPs Threatens GMP Compliance Introduction to the Audit Finding 1. Overview of the Issue SOPs referencing obsolete equipment qualification procedures create a major compliance risk. They often refer to outdated IQ/OQ/PQ protocols, misaligned forms, or legacy templates that no…

Read More “Audit Risk: Outdated Qualification Procedures in SOPs Jeopardize GMP Compliance” »

GMP Audit Findings, Validation Alignment

Posts pagination

Previous 1 … 8 9 10 … 12 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme